Raquel E Gur - Publications

Affiliations: 
 

132 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Wannan CMJ, Nelson B, Addington J, Allott K, Anticevic A, Arango C, Baker JT, Bearden CE, Billah T, Bouix S, Broome MR, Buccilli K, Cadenhead KS, Calkins ME, Cannon TD, ... ... Gur RE, ... ... Gur RC, et al. Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis. Schizophrenia Bulletin. PMID 38451304 DOI: 10.1093/schbul/sbae011  0.342
2024 Georgiadis F, Larivière S, Glahn D, Hong LE, Kochunov P, Mowry B, Loughland C, Pantelis C, Henskens FA, Green MJ, Cairns MJ, Michie PT, Rasser PE, Catts S, Tooney P, ... ... Gur R, ... ... Gur R, et al. Connectome architecture shapes large-scale cortical alterations in schizophrenia: a worldwide ENIGMA study. Molecular Psychiatry. PMID 38336840 DOI: 10.1038/s41380-024-02442-7  0.326
2023 Tandon R, Nasrallah H, Akbarian S, Carpenter WT, DeLisi LE, Gaebel W, Green MF, Gur RE, Heckers S, Kane JM, Malaspina D, Meyer-Lindenberg A, Murray R, Owen M, Smoller JW, et al. The schizophrenia syndrome, circa 2024: What we know and how that informs its nature. Schizophrenia Research. 264: 1-28. PMID 38086109 DOI: 10.1016/j.schres.2023.11.015  0.368
2023 Dwyer DB, Chand GB, Pigoni A, Khuntia A, Wen J, Antoniades M, Hwang G, Erus G, Doshi J, Srinivasan D, Varol E, Kahn RS, Schnack HG, Meisenzahl E, Wood SJ, ... Gur RE, ... Gur RC, et al. Psychosis brain subtypes validated in first-episode cohorts and related to illness remission: results from the PHENOM consortium. Molecular Psychiatry. PMID 37147389 DOI: 10.1038/s41380-023-02069-0  0.32
2023 Levinson T, Prettyman G, Savage C, White L, Moore TM, Calkins ME, Ruparel K, Gur RE, Gur RC, Satterthwaite TD, Wolf DH. Activation of Internal Correctness Monitoring Circuitry in Youths With Psychosis Spectrum Symptoms. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 37019760 DOI: 10.1016/j.bpsc.2023.01.010  0.367
2023 Brown LA, Zhu Y, Hamlett GE, Moore TM, DiDomenico GE, Visoki E, Greenberg DM, Gur RC, Gur RE, Barzilay R. COVID-19 Worries and Insomnia: A Follow-Up Study. International Journal of Environmental Research and Public Health. 20. PMID 36901578 DOI: 10.3390/ijerph20054568  0.324
2022 Xavier RM, Calkins ME, Bassett DS, Moore TM, George WT, Taylor JH, Gur RE. Characterizing Youth-Caregiver Concordance and Discrepancies in Psychopathology Symptoms in a US Community Sample. Issues in Mental Health Nursing. 1-10. PMID 35839118 DOI: 10.1080/01612840.2022.2099494  0.705
2022 Kuo SS, Roalf DR, Prasad KM, Musket CW, Rupert PE, Wood J, Gur RC, Almasy L, Gur RE, Nimgaonkar VL, Pogue-Geile MF. Age-dependent effects of schizophrenia genetic risk on cortical thickness and cortical surface area: Evaluating evidence for neurodevelopmental and neurodegenerative models of schizophrenia. Journal of Psychopathology and Clinical Science. PMID 35737559 DOI: 10.1037/abn0000765  0.31
2022 Chand GB, Singhal P, Dwyer DB, Wen J, Erus G, Doshi J, Srinivasan D, Mamourian E, Varol E, Sotiras A, Hwang G, Dazzan P, Kahn RS, Schnack HG, Zanetti MV, ... Gur RE, ... Gur RC, et al. Schizophrenia Imaging Signatures and Their Associations With Cognition, Psychopathology, and Genetics in the General Population. The American Journal of Psychiatry. appiajp21070686. PMID 35410495 DOI: 10.1176/appi.ajp.21070686  0.332
2021 Wolf DH, Zheng D, Kohler C, Turetsky BI, Ruparel K, Satterthwaite TD, Elliott MA, March ME, Cross AJ, Smith MA, Zukin SR, Gur RC, Gur RE. Effect of mGluR2 positive allosteric modulation on frontostriatal working memory activation in schizophrenia. Molecular Psychiatry. PMID 34667261 DOI: 10.1038/s41380-021-01320-w  0.388
2021 Alexander-Bloch AF, Sood R, Shinohara RT, Moore TM, Calkins ME, Chertavian C, Wolf DH, Gur RC, Satterthwaite TD, Gur RE, Barzilay R. Connectome-wide functional connectivity abnormalities in youth with obsessive compulsive symptoms. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 34375730 DOI: 10.1016/j.bpsc.2021.07.014  0.309
2021 Dong F, Calkins ME, Compton P, Medoff-Cooper B, Barzilay R, Taylor JH, Moore TM, Gur RC, Gur RE, Hodgson NA. Association between traumatic stressful events and schizotypal symptoms among a community-based sample of adolescents: A 2-year longitudinal study. Schizophrenia Research. 233: 44-51. PMID 34225026 DOI: 10.1016/j.schres.2021.06.029  0.353
2021 Parkes L, Moore TM, Calkins ME, Cook PA, Cieslak M, Roalf DR, Wolf DH, Gur RC, Gur RE, Satterthwaite TD, Bassett DS. Transdiagnostic dimensions of psychopathology explain individuals' unique deviations from normative neurodevelopment in brain structure. Translational Psychiatry. 11: 232. PMID 33879764 DOI: 10.1038/s41398-021-01342-6  0.343
2021 Gur RE, Roalf DR, Alexander-Bloch A, McDonald-McGinn DM, Gur RC. Pathways to understanding psychosis through rare - 22q11.2DS - and common variants. Current Opinion in Genetics & Development. 68: 35-40. PMID 33571729 DOI: 10.1016/j.gde.2021.01.007  0.317
2021 Olde Loohuis LM, Mennigen E, Ori APS, Perkins D, Robinson E, Addington J, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman LJ, Keshavan MS, Stone WS, Tsuang MT, Walker EF, ... ... Gur RC, ... ... Gur RE, et al. Genetic and clinical analyses of psychosis spectrum symptoms in a large multiethnic youth cohort reveal significant link with ADHD. Translational Psychiatry. 11: 80. PMID 33510130 DOI: 10.1038/s41398-021-01203-2  0.376
2021 Calkins M, Butler ER, Moore TM, Ruparel K, Wolf DH, Satterthwaite TD, Gur RC, Gur RE. Longitudinal Trajectories of Psychosis Spectrum Symptoms in Community Youth: Findings From the Philadelphia Neurodevelopmental Cohort (PNC) Biological Psychiatry. 89: S153. DOI: 10.1016/j.biopsych.2021.02.392  0.402
2021 Alexander-Bloch A, Satterthwaite T, Moore TM, Calkins ME, Shinohara R, Gur R, Barzilay R, Gur R. Altered Network-Based Functional Connectivity Associated With Obsessive-Compulsive Symptoms in Youth Biological Psychiatry. 89: S15-S16. DOI: 10.1016/j.biopsych.2021.02.059  0.319
2020 Davies RW, Fiksinski AM, Breetvelt EJ, Williams NM, Hooper SR, Monfeuga T, Bassett AS, Owen MJ, Gur RE, Morrow BE, McDonald-McGinn DM, Swillen A, Chow EWC, van den Bree M, Emanuel BS, et al. Using common genetic variation to examine phenotypic expression and risk prediction in 22q11.2 deletion syndrome. Nature Medicine. PMID 33169016 DOI: 10.1038/s41591-020-1103-1  0.346
2020 Prasad KM, Gertler J, Tollefson S, Wood JA, Roalf D, Gur RC, Gur RE, Almasy L, Pogue-Geile MF, Nimgaonkar VL. Heritable anisotropy associated with cognitive impairments among patients with schizophrenia and their non-psychotic relatives in multiplex families. Psychological Medicine. 1-12. PMID 32878667 DOI: 10.1017/S0033291720002883  0.326
2020 Musket CW, Kuo SS, Rupert PE, Almasy L, Gur RC, Prasad K, Wood J, Roalf DR, Gur RE, Nimgaonkar VL, Pogue-Geile MF. Why does age of onset predict clinical severity in schizophrenia? A multiplex extended pedigree study. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. PMID 32812349 DOI: 10.1002/Ajmg.B.32814  0.445
2020 Musket CW, Kuo SS, Rupert PE, Almasy L, Gur RC, Prasad K, Wood J, Roalf DR, Gur RE, Nimgaonkar VL, Pogue-Geile MF. Why does age of onset predict clinical severity in schizophrenia? A multiplex extended pedigree study. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. PMID 32812349 DOI: 10.1002/Ajmg.B.32814  0.445
2020 Taylor JH, Calkins ME, Gur RE. Markers of Psychosis Risk in the General Population. Biological Psychiatry. PMID 32220500 DOI: 10.1016/J.Biopsych.2020.02.002  0.407
2020 Taylor JH, Calkins ME, Gur RE. Markers of Psychosis Risk in the General Population. Biological Psychiatry. PMID 32220500 DOI: 10.1016/J.Biopsych.2020.02.002  0.407
2020 DeStefano L, White LK, Moore T, Ruparel K, Satterthwaite T, Wolf D, Barzilay R, Turetsky B, Roalf D, Kohler C, Gur R, Gur R, Calkins M. Association of Mood Disturbance With Positive Symptom Phenomenology During Late Adolescence/ Early Adulthood Biological Psychiatry. 87: S366-S367. DOI: 10.1016/J.Biopsych.2020.02.939  0.301
2020 Chand G, Wolf DH, Erus G, Srinivasan D, Dwyer DB, Pomponio R, Sotiras A, Varol E, Doshi J, Pigoni A, Dazzan P, Kahn RS, Schnack HG, Zanetti MV, Meisenzahl E, ... Gur RE, ... Gur RC, et al. Neuroanatomical Dimensional Phenotypes of Schizophrenia: Expression in Youth With Psychosis-Spectrum Symptoms and Correlation With Cognition Biological Psychiatry. 87: S119. DOI: 10.1016/J.Biopsych.2020.02.324  0.376
2020 Kaczkurkin A, Sotiras A, Baller E, Barzilay R, Calkins ME, Chand G, Cui Z, Erus G, Fan Y, Gur RE, Gur RC, Moore TM, Roalf D, Rosen AF, Ruparel K, et al. Neurostructural Heterogeneity in Youth With Internalizing Symptoms Biological Psychiatry. 87: S28. DOI: 10.1016/j.biopsych.2020.02.096  0.367
2019 Taylor JH, Asabere N, Calkins ME, Moore TM, Tang SX, Xavier RM, Merikangas AK, Wolf DH, Almasy L, Gur RC, Gur RE. Characteristics of youth with reported family history of psychosis spectrum symptoms in the Philadelphia Neurodevelopmental Cohort. Schizophrenia Research. PMID 31883930 DOI: 10.1016/J.Schres.2019.12.021  0.727
2019 Taylor JH, Asabere N, Calkins ME, Moore TM, Tang SX, Xavier RM, Merikangas AK, Wolf DH, Almasy L, Gur RC, Gur RE. Characteristics of youth with reported family history of psychosis spectrum symptoms in the Philadelphia Neurodevelopmental Cohort. Schizophrenia Research. PMID 31883930 DOI: 10.1016/J.Schres.2019.12.021  0.727
2019 Barzilay R, Patrick A, Calkins ME, Moore TM, Gur RC, Gur RE. Association between early-life trauma and obsessive compulsive symptoms in community youth. Depression and Anxiety. PMID 31066996 DOI: 10.1002/Da.22907  0.329
2019 Barzilay R, Patrick A, Calkins ME, Moore TM, Gur RC, Gur RE. Association between early-life trauma and obsessive compulsive symptoms in community youth. Depression and Anxiety. PMID 31066996 DOI: 10.1002/Da.22907  0.329
2019 Jalbrzikowski M, Freedman D, Hegarty CE, Mennigen E, Karlsgodt KH, Olde Loohuis LM, Ophoff RA, Gur RE, Bearden CE. Structural Brain Alterations in Youth With Psychosis and Bipolar Spectrum Symptoms. Journal of the American Academy of Child and Adolescent Psychiatry. PMID 30768396 DOI: 10.1016/J.Jaac.2018.11.012  0.316
2019 Jalbrzikowski M, Freedman D, Hegarty CE, Mennigen E, Karlsgodt KH, Olde Loohuis LM, Ophoff RA, Gur RE, Bearden CE. Structural Brain Alterations in Youth With Psychosis and Bipolar Spectrum Symptoms. Journal of the American Academy of Child and Adolescent Psychiatry. PMID 30768396 DOI: 10.1016/J.Jaac.2018.11.012  0.316
2019 Barzilay R, Patrick A, Calkins ME, Moore TM, Wolf DH, Benton TD, Leckman JF, Gur RC, Gur RE. Obsessive-Compulsive Symptomatology in Community Youth: Typical Development or a Red Flag for Psychopathology? Journal of the American Academy of Child and Adolescent Psychiatry. 58: 277-286.e4. PMID 30738554 DOI: 10.1016/J.Jaac.2018.06.038  0.311
2019 Barzilay R, Patrick A, Calkins ME, Moore TM, Wolf DH, Benton TD, Leckman JF, Gur RC, Gur RE. Obsessive-Compulsive Symptomatology in Community Youth: Typical Development or a Red Flag for Psychopathology? Journal of the American Academy of Child and Adolescent Psychiatry. 58: 277-286.e4. PMID 30738554 DOI: 10.1016/J.Jaac.2018.06.038  0.311
2019 Roalf DR, de la Garza AG, Rosen A, Calkins ME, Moore TM, Quarmley M, Ruparel K, Xia CH, Rupert PE, Satterthwaite TD, Shinohara RT, Elliott MA, Gur RC, Gur RE. Alterations in white matter microstructure in individuals at persistent risk for psychosis. Molecular Psychiatry. PMID 30723287 DOI: 10.1038/S41380-019-0360-1  0.398
2019 Roalf DR, de la Garza AG, Rosen A, Calkins ME, Moore TM, Quarmley M, Ruparel K, Xia CH, Rupert PE, Satterthwaite TD, Shinohara RT, Elliott MA, Gur RC, Gur RE. Alterations in white matter microstructure in individuals at persistent risk for psychosis. Molecular Psychiatry. PMID 30723287 DOI: 10.1038/S41380-019-0360-1  0.398
2018 Niarchou M, Chawner SJRA, Fiksinski A, Vorstman JAS, Maeder J, Schneider M, Eliez S, Armando M, Pontillo M, Vicari S, McDonald-McGinn DM, Emanuel BS, Zackai EH, Bearden CE, Shashi V, ... ... Gur RE, et al. Attention deficit hyperactivity disorder symptoms as antecedents of later psychotic outcomes in 22q11.2 deletion syndrome. Schizophrenia Research. PMID 30093352 DOI: 10.1016/J.Schres.2018.07.044  0.318
2018 Shafee R, Nanda P, Padmanabhan JL, Tandon N, Alliey-Rodriguez N, Kalapurakkel S, Weiner DJ, Gur RE, Keefe RSE, Hill SK, Bishop JR, Clementz BA, Tamminga CA, Gershon ES, Pearlson GD, et al. Polygenic risk for schizophrenia and measured domains of cognition in individuals with psychosis and controls. Translational Psychiatry. 8: 78. PMID 29643358 DOI: 10.1038/S41398-018-0124-8  0.524
2018 Kuo SS, Almasy L, Gur RC, Prasad K, Roalf DR, Gur RE, Nimgaonkar VL, Pogue-Geile MF. Cognition and community functioning in schizophrenia: The nature of the relationship. Journal of Abnormal Psychology. 127: 216-227. PMID 29528675 DOI: 10.1037/Abn0000326  0.32
2017 Tang SX, Gur RE. Longitudinal perspectives on the psychosis spectrum in 22q11.2 deletion syndrome. American Journal of Medical Genetics. Part A. PMID 29048724 DOI: 10.1002/ajmg.a.38500  0.349
2017 Niarchou M, Calkins ME, Moore TM, Tang SX, McDonald-McGinn DM, Zackai EH, Emanuel BS, Gur RC, Gur RE. Attention Deficit Hyperactivity Disorder Symptoms and Psychosis in 22q11.2 Deletion Syndrome. Schizophrenia Bulletin. PMID 29040797 DOI: 10.1093/Schbul/Sbx113  0.348
2017 Kaczkurkin AN, Moore TM, Calkins ME, Ciric R, Detre JA, Elliott MA, Foa EB, Garcia de la Garza A, Roalf DR, Rosen A, Ruparel K, Shinohara RT, Xia CH, Wolf DH, Gur RE, Gur RC, et al. Common and dissociable regional cerebral blood flow differences associate with dimensions of psychopathology across categorical diagnoses. Molecular Psychiatry. PMID 28924181 DOI: 10.1038/Mp.2017.174  0.303
2017 Tang SX, Moore TM, Calkins ME, Yi JJ, McDonald-McGinn DM, Zackai EH, Emanuel BS, Gur RC, Gur RE. Emergent, remitted and persistent psychosis-spectrum symptoms in 22q11.2 deletion syndrome. Translational Psychiatry. 7: e1180. PMID 28742080 DOI: 10.1038/Tp.2017.157  0.401
2017 Walton E, Hibar DP, van Erp TGM, Potkin SG, Roiz-Santiañez R, Crespo-Facorro B, Suarez-Pinilla P, van Haren NEM, de Zwarte SMC, Kahn RS, Cahn W, Doan NT, Jørgensen KN, Gurholt TP, Agartz I, ... Gur RE, ... Gur RC, et al. Prefrontal cortical thinning links to negative symptoms in schizophrenia via the ENIGMA consortium. Psychological Medicine. 1-13. PMID 28545597 DOI: 10.1017/S0033291717001283  0.392
2017 Walton E, Hibar DP, van Erp TG, Potkin SG, Roiz-Santiañez R, Crespo-Facorro B, Suarez-Pinilla P, Van Haren NE, de Zwarte SM, Kahn RS, Cahn W, Doan NT, Jørgensen KN, Gurholt TP, Agartz I, ... ... Gur RE, ... ... Gur RC, et al. Positive symptoms associate with cortical thinning in the superior temporal gyrus via the ENIGMA Schizophrenia consortium. Acta Psychiatrica Scandinavica. PMID 28369804 DOI: 10.1111/Acps.12718  0.331
2017 Jones JD, Calkins ME, Scott JC, Bach EC, Gur RE. Cannabis Use, Polysubstance Use, and Psychosis Spectrum Symptoms in a Community-Based Sample of U.S. Youth. The Journal of Adolescent Health : Official Publication of the Society For Adolescent Medicine. PMID 28318911 DOI: 10.1016/J.Jadohealth.2017.01.006  0.32
2017 Weisman O, Guri Y, Gur RE, McDonald-McGinn DM, Calkins ME, Tang SX, Emanuel B, Zackai EH, Eliez S, Schneider M, Schaer M, Kates WR, Antshel KM, Fremont W, Shashi V, et al. Subthreshold Psychosis in 22q11.2 Deletion Syndrome: Multisite Naturalistic Study. Schizophrenia Bulletin. PMID 28204757 DOI: 10.1093/Schbul/Sbx005  0.317
2017 Calkins ME, Moore TM, Satterthwaite TD, Wolf DH, Turetsky BI, Roalf DR, Merikangas KR, Ruparel K, Kohler CG, Gur RC, Gur RE. Persistence of psychosis spectrum symptoms in the Philadelphia Neurodevelopmental Cohort: a prospective two-year follow-up. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 16: 62-76. PMID 28127907 DOI: 10.1002/Wps.20386  0.456
2017 Gur R, Yi J, Tang S, Calkins M, Moore T, Schmitt J, McDonald-McGinn D, Zackai E, Xie M, Gur R, Emanuel B. Psychosis Risk In 22Q11.2 Deletion Syndrome: Findings From The Philadelphia Sample European Neuropsychopharmacology. 27: S480. DOI: 10.1016/J.Euroneuro.2016.09.566  0.485
2016 Mekori-Domachevsky E, Guri Y, Yi J, Weisman O, Calkins ME, Tang SX, Gross R, McDonald-McGinn DM, Emanuel BS, Zackai EH, Zalsman G, Weizman A, Gur RC, Gur RE, Gothelf D. Negative subthreshold psychotic symptoms distinguish 22q11.2 deletion syndrome from other neurodevelopmental disorders: A two-site study. Schizophrenia Research. PMID 28041919 DOI: 10.1016/J.Schres.2016.12.023  0.312
2016 Thomas ML, Green MF, Hellemann G, Sugar CA, Tarasenko M, Calkins ME, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Nuechterlein KH, Radant AD, Seidman LJ, Shiluk AL, Siever LJ, et al. Modeling Deficits From Early Auditory Information Processing to Psychosocial Functioning in Schizophrenia. Jama Psychiatry. PMID 27926742 DOI: 10.1001/Jamapsychiatry.2016.2980  0.318
2016 Germine L, Robinson EB, Smoller JW, Calkins ME, Moore TM, Hakonarson H, Daly MJ, Lee PH, Holmes AJ, Buckner RL, Gur RC, Gur RE. Association between polygenic risk for schizophrenia, neurocognition and social cognition across development. Translational Psychiatry. 6: e924. PMID 27754483 DOI: 10.1038/Tp.2016.147  0.329
2016 Roalf DR, Quarmley M, Calkins ME, Satterthwaite TD, Ruparel K, Elliott MA, Moore TM, Gur RC, Gur RE, Moberg PJ, Turetsky BI. Temporal Lobe Volume Decrements in Psychosis Spectrum Youths. Schizophrenia Bulletin. PMID 27559077 DOI: 10.1093/Schbul/Sbw112  0.361
2016 Sommer IE, Bearden CE, van Dellen E, Breetvelt EJ, Duijff SN, Maijer K, van Amelsvoort T, de Haan L, Gur RE, Arango C, Díaz-Caneja CM, Vinkers CH, Vorstman JA. Early interventions in risk groups for schizophrenia: what are we waiting for? Npj Schizophrenia. 2: 16003. PMID 27336054 DOI: 10.1038/npjschz.2016.3  0.33
2016 Millard SP, Shofer J, Braff D, Calkins M, Cadenhead K, Freedman R, Green MF, Greenwood TA, Gur R, Gur R, Lazzeroni LC, Light GA, Olincy A, Nuechterlein K, Seidman L, et al. Prioritizing schizophrenia endophenotypes for future genetic studies: An example using data from the COGS-1 family study. Schizophrenia Research. PMID 27132484 DOI: 10.1016/J.Schres.2016.04.011  0.321
2016 Satterthwaite TD, Wolf DH, Calkins ME, Vandekar SN, Erus G, Ruparel K, Roalf DR, Linn KA, Elliott MA, Moore TM, Hakonarson H, Shinohara RT, Davatzikos C, Gur RC, Gur RE. Structural Brain Abnormalities in Youth With Psychosis Spectrum Symptoms. Jama Psychiatry. PMID 26982085 DOI: 10.1001/Jamapsychiatry.2015.3463  0.395
2015 Jahn DR, Bennett ME, Park SG, Gur RE, Horan WP, Kring AM, Blanchard JJ. The interactive effects of negative symptoms and social role functioning on suicide ideation in individuals with schizophrenia. Schizophrenia Research. PMID 26746862 DOI: 10.1016/J.Schres.2015.12.011  0.319
2015 Kos MZ, Carless MA, Peralta J, Blackburn A, Almeida M, Roalf D, Pogue-Geile MF, Prasad K, Gur RC, Nimgaonkar V, Curran JE, Duggirala R, Glahn DC, Blangero J, Gur RE, et al. Exome Sequence Data From Multigenerational Families Implicate AMPA Receptor Trafficking in Neurocognitive Impairment and Schizophrenia Risk. Schizophrenia Bulletin. PMID 26405221 DOI: 10.1093/Schbul/Sbv135  0.344
2015 Xu T, Wang Y, Li Z, Huang J, Lui SS, Tan SP, Yu X, Cheung EF, He MG, Ott J, Gur RE, Gur RC, Chan RC. Heritability and familiality of neurological soft signs: evidence from healthy twins, patients with schizophrenia and non-psychotic first-degree relatives. Psychological Medicine. 1-7. PMID 26347209 DOI: 10.1017/S0033291715001580  0.308
2015 Gur RE, March M, Calkins ME, Weittenhiller L, Wolf DH, Turetsky BI, Gur RC. Negative symptoms in youths with psychosis spectrum features: Complementary scales in relation to neurocognitive performance and function. Schizophrenia Research. 166: 322-7. PMID 26093946 DOI: 10.1016/J.Schres.2015.05.037  0.42
2015 Chan RC, Geng FL, Lui SS, Wang Y, Ho KK, Hung KS, Gur RE, Gur RC, Cheung EF. Course of neurological soft signs in first-episode schizophrenia: Relationship with negative symptoms and cognitive performances. Scientific Reports. 5: 11053. PMID 26053141 DOI: 10.1038/Srep11053  0.397
2015 Satterthwaite TD, Vandekar SN, Wolf DH, Bassett DS, Ruparel K, Shehzad Z, Craddock RC, Shinohara RT, Moore TM, Gennatas ED, Jackson C, Roalf DR, Milham MP, Calkins ME, Hakonarson H, Gur RC, ... Gur RE, et al. Connectome-wide network analysis of youth with Psychosis-Spectrum symptoms. Molecular Psychiatry. PMID 26033240 DOI: 10.1038/Mp.2015.66  0.325
2015 Wolf DH, Satterthwaite TD, Calkins ME, Ruparel K, Elliott MA, Hopson RD, Jackson CT, Prabhakaran K, Bilker WB, Hakonarson H, Gur RC, Gur RE. Functional neuroimaging abnormalities in youth with psychosis spectrum symptoms. Jama Psychiatry. 72: 456-65. PMID 25785510 DOI: 10.1001/Jamapsychiatry.2014.3169  0.436
2015 Nuechterlein KH, Green MF, Calkins ME, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, et al. Attention/vigilance in schizophrenia: performance results from a large multi-site study of the Consortium on the Genetics of Schizophrenia (COGS). Schizophrenia Research. 163: 38-46. PMID 25749017 DOI: 10.1016/J.Schres.2015.01.017  0.332
2015 Radant AD, Millard SP, Braff DL, Calkins ME, Dobie DJ, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Meichle SP, Nuechterlein KH, Olincy A, et al. Robust differences in antisaccade performance exist between COGS schizophrenia cases and controls regardless of recruitment strategies. Schizophrenia Research. 163: 47-52. PMID 25553977 DOI: 10.1016/J.Schres.2014.12.016  0.315
2015 Roalf DR, Gur RE, Verma R, Parker WA, Quarmley M, Ruparel K, Gur RC. White matter microstructure in schizophrenia: associations to neurocognition and clinical symptomatology. Schizophrenia Research. 161: 42-9. PMID 25445621 DOI: 10.1016/J.Schres.2014.09.026  0.328
2015 Gur RC, Braff DL, Calkins ME, Dobie DJ, Freedman R, Green MF, Greenwood TA, Lazzeroni LC, Light GA, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, ... Gur RE, et al. Neurocognitive performance in family-based and case-control studies of schizophrenia. Schizophrenia Research. 163: 17-23. PMID 25432636 DOI: 10.1016/J.Schres.2014.10.049  0.307
2015 Gur RE, March M, Calkins ME, Weittenhiller L, Wolf DH, Turetsky BI, Gur RC. Negative symptoms in youths with psychosis spectrum features: Complementary scales in relation to neurocognitive performance and function Schizophrenia Research. DOI: 10.1016/j.schres.2015.05.037  0.337
2014 Calkins ME, Moore TM, Merikangas KR, Burstein M, Satterthwaite TD, Bilker WB, Ruparel K, Chiavacci R, Wolf DH, Mentch F, Qiu H, Connolly JJ, Sleiman PA, Hakonarson H, Gur RC, Gur RE, et al. The psychosis spectrum in a young U.S. community sample: findings from the Philadelphia Neurodevelopmental Cohort. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 13: 296-305. PMID 25273303 DOI: 10.1002/Wps.20152  0.456
2014 Felice Reddy L, Green MF, Rizzo S, Sugar CA, Blanchard JJ, Gur RE, Kring AM, Horan WP. Behavioral approach and avoidance in schizophrenia: an evaluation of motivational profiles. Schizophrenia Research. 159: 164-70. PMID 25153364 DOI: 10.1016/J.Schres.2014.07.047  0.332
2014 Tsuang D, Esterberg M, Braff D, Calkins M, Cadenhead K, Dobie D, Freedman R, Green MF, Greenwood T, Gur R, Gur R, Horan W, Lazzeroni LC, Light GA, Millard SP, et al. Is there an association between advanced paternal age and endophenotype deficit levels in schizophrenia? Plos One. 9: e88379. PMID 24523888 DOI: 10.1371/Journal.Pone.0088379  0.351
2014 Gur RC, Calkins ME, Satterthwaite TD, Ruparel K, Bilker WB, Moore TM, Savitt AP, Hakonarson H, Gur RE. Neurocognitive growth charting in psychosis spectrum youths. Jama Psychiatry. 71: 366-74. PMID 24499990 DOI: 10.1001/Jamapsychiatry.2013.4190  0.385
2014 Moberg PJ, Kamath V, Marchetto DM, Calkins ME, Doty RL, Hahn CG, Borgmann-Winter KE, Kohler CG, Gur RE, Turetsky BI. Meta-analysis of olfactory function in schizophrenia, first-degree family members, and youths at-risk for psychosis. Schizophrenia Bulletin. 40: 50-9. PMID 23641047 DOI: 10.1093/Schbul/Sbt049  0.309
2013 Tandon R, Gaebel W, Barch DM, Bustillo J, Gur RE, Heckers S, Malaspina D, Owen MJ, Schultz S, Tsuang M, Van Os J, Carpenter W. Definition and description of schizophrenia in the DSM-5. Schizophrenia Research. 150: 3-10. PMID 23800613 DOI: 10.1016/J.Schres.2013.05.028  0.337
2013 Tsuang MT, Van Os J, Tandon R, Barch DM, Bustillo J, Gaebel W, Gur RE, Heckers S, Malaspina D, Owen MJ, Schultz S, Carpenter W. Attenuated psychosis syndrome in DSM-5. Schizophrenia Research. 150: 31-5. PMID 23773295 DOI: 10.1016/J.Schres.2013.05.004  0.3
2013 Barch DM, Bustillo J, Gaebel W, Gur R, Heckers S, Malaspina D, Owen MJ, Schultz S, Tandon R, Tsuang M, Van Os J, Carpenter W. Logic and justification for dimensional assessment of symptoms and related clinical phenomena in psychosis: relevance to DSM-5. Schizophrenia Research. 150: 15-20. PMID 23706415 DOI: 10.1016/J.Schres.2013.04.027  0.401
2013 Calkins ME, Ray A, Gur RC, Freedman R, Green MF, Greenwood TA, Light GA, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Sugar C, ... Gur RE, et al. Sex differences in familiality effects on neurocognitive performance in schizophrenia. Biological Psychiatry. 73: 976-84. PMID 23395246 DOI: 10.1016/J.Biopsych.2012.12.021  0.304
2013 Kring AM, Gur RE, Blanchard JJ, Horan WP, Reise SP. The Clinical Assessment Interview for Negative Symptoms (CAINS): final development and validation. The American Journal of Psychiatry. 170: 165-72. PMID 23377637 DOI: 10.1176/Appi.Ajp.2012.12010109  0.348
2013 Roalf DR, Gur RC, Almasy L, Richard J, Gallagher RS, Prasad K, Wood J, Pogue-Geile MF, Nimgaonkar VL, Gur RE. Neurocognitive performance stability in a multiplex multigenerational study of schizophrenia. Schizophrenia Bulletin. 39: 1008-17. PMID 22927671 DOI: 10.1093/Schbul/Sbs078  0.311
2012 Tarbox SI, Almasy L, Gur RE, Nimgaonkar VL, Pogue-Geile MF. The nature of schizotypy among multigenerational multiplex schizophrenia families. Journal of Abnormal Psychology. 121: 396-406. PMID 22288909 DOI: 10.1037/A0026787  0.339
2012 Yokley JL, Prasad KM, Chowdari KV, Talkowski ME, Wood J, Gur RC, Gur RE, Almasy L, Nimgaonkar VL, Pogue-Geile MF. Genetic associations between neuregulin-1 SNPs and neurocognitive function in multigenerational, multiplex schizophrenia families. Psychiatric Genetics. 22: 70-81. PMID 22183611 DOI: 10.1097/Ypg.0B013E32834F352C  0.329
2012 Goldenberg PC, Calkins ME, Richard J, McDonald-McGinn D, Zackai E, Mitra N, Emanuel B, Devoto M, Borgmann-Winter K, Kohler C, Conroy CG, Gur RC, Gur RE. Computerized neurocognitive profile in young people with 22q11.2 deletion syndrome compared to youths with schizophrenia and at-risk for psychosis. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 159: 87-93. PMID 22170773 DOI: 10.1002/Ajmg.B.32005  0.367
2011 Horan WP, Kring AM, Gur RE, Reise SP, Blanchard JJ. Development and psychometric validation of the Clinical Assessment Interview for Negative Symptoms (CAINS). Schizophrenia Research. 132: 140-5. PMID 21798716 DOI: 10.1016/J.Schres.2011.06.030  0.376
2011 Leitman DI, Wolf DH, Laukka P, Ragland JD, Valdez JN, Turetsky BI, Gur RE, Gur RC. Not pitch perfect: sensory contributions to affective communication impairment in schizophrenia. Biological Psychiatry. 70: 611-8. PMID 21762876 DOI: 10.1016/J.Biopsych.2011.05.032  0.338
2011 Stone WS, Giuliano AJ, Tsuang MT, Braff DL, Cadenhead KS, Calkins ME, Dobie DJ, Faraone SV, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, et al. Group and site differences on the California Verbal Learning Test in persons with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia (COGS). Schizophrenia Research. 128: 102-10. PMID 21288694 DOI: 10.1016/J.Schres.2011.01.005  0.311
2011 Gur RE. Neuropsychiatric Aspects of Schizophrenia Cns Neuroscience and Therapeutics. 17: 45-51. PMID 21199445 DOI: 10.1111/j.1755-5949.2010.00220.x  0.31
2011 Blanchard JJ, Kring AM, Horan WP, Gur R. Toward the next generation of negative symptom assessments: the collaboration to advance negative symptom assessment in schizophrenia. Schizophrenia Bulletin. 37: 291-9. PMID 20861151 DOI: 10.1093/Schbul/Sbq104  0.408
2010 Forbes C, Blanchard JJ, Bennett M, Horan WP, Kring A, Gur R. Initial development and preliminary validation of a new negative symptom measure: the Clinical Assessment Interview for Negative Symptoms (CAINS). Schizophrenia Research. 124: 36-42. PMID 20869848 DOI: 10.1016/J.Schres.2010.08.039  0.377
2010 Glessner JT, Reilly MP, Kim CE, Takahashi N, Albano A, Hou C, Bradfield JP, Zhang H, Sleiman PM, Flory JH, Imielinski M, Frackelton EC, Chiavacci R, Thomas KA, Garris M, ... ... Gur RE, et al. Strong synaptic transmission impact by copy number variations in schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 107: 10584-9. PMID 20489179 DOI: 10.1073/Pnas.1000274107  0.302
2010 Radant AD, Dobie DJ, Calkins ME, Olincy A, Braff DL, Cadenhead KS, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Meichle SP, Millard SP, Mintz J, et al. Antisaccade performance in schizophrenia patients, their first-degree biological relatives, and community comparison subjects: data from the COGS study. Psychophysiology. 47: 846-56. PMID 20374545 DOI: 10.1111/J.1469-8986.2010.01004.X  0.314
2010 Satterthwaite TD, Wolf DH, Loughead J, Ruparel K, Valdez JN, Siegel SJ, Kohler CG, Gur RE, Gur RC. Association of enhanced limbic response to threat with decreased cortical facial recognition memory response in schizophrenia. The American Journal of Psychiatry. 167: 418-26. PMID 20194482 DOI: 10.1176/Appi.Ajp.2009.09060808  0.336
2010 Calkins ME, Tepper P, Gur RC, Ragland JD, Klei L, Wiener HW, Richard J, Savage RM, Allen TB, O'Jile J, Devlin B, Kwentus J, Aliyu MH, Bradford LD, Edwards N, ... Gur RE, et al. Project among African-Americans to explore risks for schizophrenia (PAARTNERS): evidence for impairment and heritability of neurocognitive functioning in families of schizophrenia patients. The American Journal of Psychiatry. 167: 459-72. PMID 20194479 DOI: 10.1176/Appi.Ajp.2009.08091351  0.354
2010 Keutmann MK, Gur RE, Gur RC. Understanding emotion processing in schizophrenia Die Psychiatrie. 7: 217-226. DOI: 10.1055/s-0038-1669583  0.331
2009 Wiener HW, Klei L, Irvin MD, Perry RT, Aliyu MH, Allen TB, Bradford LD, Calkins ME, Devlin B, Edwards N, Gur RE, Gur RC, Kwentus J, Lyons PD, McEvoy JP, et al. Linkage analysis of schizophrenia in African-American families. Schizophrenia Research. 109: 70-9. PMID 19264455 DOI: 10.1016/J.Schres.2009.02.007  0.306
2009 Turetsky BI, Bilker WB, Siegel SJ, Kohler CG, Gur RE. Profile of auditory information-processing deficits in schizophrenia. Psychiatry Research. 165: 27-37. PMID 18990453 DOI: 10.1016/J.Psychres.2008.04.013  0.31
2008 Almasy L, Gur RC, Haack K, Cole SA, Calkins ME, Peralta JM, Hare E, Prasad K, Pogue-Geile MF, Nimgaonkar V, Gur RE. A genome screen for quantitative trait loci influencing schizophrenia and neurocognitive phenotypes. The American Journal of Psychiatry. 165: 1185-92. PMID 18628350 DOI: 10.1176/Appi.Ajp.2008.07121869  0.309
2008 Horan WP, Braff DL, Nuechterlein KH, Sugar CA, Cadenhead KS, Calkins ME, Dobie DJ, Freedman R, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Olincy A, Radant AD, et al. Verbal working memory impairments in individuals with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia. Schizophrenia Research. 103: 218-28. PMID 18406578 DOI: 10.1016/J.Schres.2008.02.014  0.305
2007 Kohler CG, Martin EA, Kujawski E, Bilker W, Gur RE, Gur RC. No effect of donepezil on neurocognition and social cognition in young persons with stable schizophrenia. Cognitive Neuropsychiatry. 12: 412-21. PMID 17690999 DOI: 10.1080/13546800701307263  0.315
2007 Gur RE, Keshavan MS, Lawrie SM. Deconstructing psychosis with human brain imaging. Schizophrenia Bulletin. 33: 921-31. PMID 17548845 DOI: 10.1093/schbul/sbm045  0.318
2007 Gur RE, Nimgaonkar VL, Almasy L, Calkins ME, Ragland JD, Pogue-Geile MF, Kanes S, Blangero J, Gur RC. Neurocognitive endophenotypes in a multiplex multigenerational family study of schizophrenia. The American Journal of Psychiatry. 164: 813-9. PMID 17475741 DOI: 10.1176/AJP.2007.164.5.813  0.304
2007 Moberg PJ, McGue C, Kanes SJ, Roalf DR, Balderston CC, Gur RE, Kohler CG, Turetsky BI. Phenylthiocarbamide (PTC) perception in patients with schizophrenia and first-degree family members: relationship to clinical symptomatology and psychophysical olfactory performance. Schizophrenia Research. 90: 221-8. PMID 17208411 DOI: 10.1016/j.schres.2006.11.014  0.33
2007 Calkins ME, Dobie DJ, Cadenhead KS, Olincy A, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Nuechterlein KH, Radant AD, Schork NJ, Seidman LJ, et al. The Consortium on the Genetics of Endophenotypes in Schizophrenia: model recruitment, assessment, and endophenotyping methods for a multisite collaboration. Schizophrenia Bulletin. 33: 33-48. PMID 17035358 DOI: 10.1093/Schbul/Sbl044  0.308
2006 Aliyu MH, Calkins ME, Swanson CL, Lyons PD, Savage RM, May R, Wiener H, McLeod-Bryant S, Devlin B, Nimgaonkar VL, Ragland JD, Gur RE, Gur RC, Bradford LD, Edwards N, et al. Project among African-Americans to explore risks for schizophrenia (PAARTNERS): recruitment and assessment methods. Schizophrenia Research. 87: 32-44. PMID 16887335 DOI: 10.1016/J.Schres.2006.06.027  0.346
2006 Siegel SJ, Irani F, Brensinger CM, Kohler CG, Bilker WB, Ragland JD, Kanes SJ, Gur RC, Gur RE. Prognostic variables at intake and long-term level of function in schizophrenia. The American Journal of Psychiatry. 163: 433-41. PMID 16513864 DOI: 10.1176/Appi.Ajp.163.3.433  0.375
2005 Kurtz MM, Moberg PJ, Ragland JD, Gur RC, Gur RE. Symptoms versus neurocognitive test performance as predictors of psychosocial status in schizophrenia: a 1- and 4-year prospective study. Schizophrenia Bulletin. 31: 167-74. PMID 15888434 DOI: 10.1093/Schbul/Sbi004  0.399
2005 Lieberman JA, Tollefson GD, Charles C, Zipursky R, Sharma T, Kahn RS, Keefe RS, Green AI, Gur RE, McEvoy J, Perkins D, Hamer RM, Gu H, Tohen M. Antipsychotic drug effects on brain morphology in first-episode psychosis. Archives of General Psychiatry. 62: 361-70. PMID 15809403 DOI: 10.1001/Archpsyc.62.4.361  0.47
2005 Moberg PJ, Roalf DR, Balderston CC, Kanes SJ, Gur RE, Turetsky BI. Phenylthiocarbamide perception in patients with schizophrenia and first-degree family members. The American Journal of Psychiatry. 162: 788-90. PMID 15800154 DOI: 10.1176/Appi.Ajp.162.4.788  0.329
2004 Perkins DO, Lieberman JA, Gu H, Tohen M, McEvoy J, Green AI, Zipursky RB, Strakowski SM, Sharma T, Kahn RS, Gur R, Tollefson G. Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders British Journal of Psychiatry. 185: 18-24. PMID 15231551 DOI: 10.1192/Bjp.185.1.18  0.321
2004 Gelber EI, Kohler CG, Bilker WB, Gur RC, Brensinger C, Siegel SJ, Gur RE. Symptom and demographic profiles in first-episode schizophrenia. Schizophrenia Research. 67: 185-94. PMID 14984877 DOI: 10.1016/S0920-9964(03)00083-5  0.335
2003 Gur RE, Kohler C, Ragland JD, Siegel SJ, Bilker WB, Loughead J, Phend N, Gur RC. Neurocognitive performance and clinical changes in olanzapine-treated patients with schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 2029-36. PMID 12902996 DOI: 10.1038/Sj.Npp.1300275  0.36
2003 Lieberman JA, Tollefson G, Tohen M, Green AI, Gur RE, Kahn R, McEvoy J, Perkins D, Sharma T, Zipursky R, Wei H, Hamer RM. Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol. The American Journal of Psychiatry. 160: 1396-404. PMID 12900300 DOI: 10.1176/Appi.Ajp.160.8.1396  0.307
2003 Kurtz MM, Moberg PJ, Ragland JD, Gur RC, Gur RE. Symptoms versus neurocognitive test performance as predictors of psychosocial status in schizophrenia: A one- and four-year prospective study Schizophrenia Research. 60: 142. DOI: 10.1016/S0920-9964(03)80950-7  0.385
2002 McBride T, Moberg PJ, Arnold SE, Mozley LH, Mahr RN, Gibney M, Kumar A, Gur RE. Neuropsychological functioning in elderly patients with schizophrenia and Alzheimer's disease. Schizophrenia Research. 55: 217-27. PMID 12048145 DOI: 10.1016/S0920-9964(01)00232-8  0.318
2001 Gur RC, Ragland JD, Moberg PJ, Bilker WB, Kohler C, Siegel SJ, Gur RE. Computerized neurocognitive scanning: II. The profile of schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 25: 777-88. PMID 11682261 DOI: 10.1016/S0893-133X(01)00279-2  0.352
1999 Gur RE, Turetsky BI, Bilker WB, Gur RC. Reduced gray matter volume in schizophrenia. Archives of General Psychiatry. 56: 905-11. PMID 10530632 DOI: 10.1001/Archpsyc.56.10.905  0.304
1998 Gur RE, Maany V, Mozley PD, Swanson C, Bilker W, Gur RC. Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia. The American Journal of Psychiatry. 155: 1711-7. PMID 9842780 DOI: 10.1176/Ajp.155.12.1711  0.305
1998 Gur RE, Cowell P, Turetsky BI, Gallacher F, Cannon T, Bilker W, Gur RC. A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures. Archives of General Psychiatry. 55: 145-52. PMID 9477928 DOI: 10.1001/Archpsyc.55.2.145  0.329
1997 Censits DM, Ragland JD, Gur RC, Gur RE. Neuropsychological evidence supporting a neurodevelopmental model of schizophrenia: a longitudinal study. Schizophrenia Research. 24: 289-98. PMID 9134589 DOI: 10.1016/S0920-9964(96)00091-6  0.311
1997 Gur RC, Ragland JD, Gur RE. Cognitive changes in schizophrenia - A critical look International Review of Psychiatry. 9: 449-457. DOI: 10.1080/09540269775312  0.364
1997 Swanson CL, Turetsky BI, Bilker W, Gur RC, Gur RE. Rater gender and symptom ratings of patients with schizophrenia Schizophrenia Research. 24: 23. DOI: 10.1016/S0920-9964(97)82065-8  0.366
1997 Kohler C, Gur RC, Mozley LH, Gur RE. Symptom and disease specificity of brain behavior funcfions in bipolar disorder and schizophrenia Schizophrenia Research. 24: 18. DOI: 10.1016/S0920-9964(97)82048-8  0.329
1996 Gur RE, Petty RG, Turetsky BI, Gur RC. Schizophrenia throughout life: sex differences in severity and profile of symptoms. Schizophrenia Research. 21: 1-12. PMID 8864248 DOI: 10.1016/0920-9964(96)00023-0  0.415
1996 Cowell PE, Kostianovsky DJ, Gur RC, Turetsky BI, Gur RE. Sex differences in neuroanatomical and clinical correlations in schizophrenia. The American Journal of Psychiatry. 153: 799-805. PMID 8633693  0.348
1996 Kohler C, Gur R, Harper Mozley L, Swanson C, Gur R. Metabolic patterns associated with depressive symptoms in schizophrenia Biological Psychiatry. 39: 604. DOI: 10.1016/0006-3223(96)84296-X  0.315
1995 Arnold SE, Gur RE, Shapiro RM, Fisher KR, Moberg PJ, Gibney MR, Gur RC, Blackwell P, Trojanowski JQ. Prospective clinicopathologic studies of schizophrenia: accrual and assessment of patients. The American Journal of Psychiatry. 152: 731-7. PMID 7726313 DOI: 10.1176/ajp.152.5.731  0.355
1994 Mozley PD, Gur RE, Resnick SM, Shtasel DL, Richards J, Kohn M, Grossman R, Herman G, Gur RC. Magnetic resonance imaging in schizophrenia: relationship with clinical measures. Schizophrenia Research. 12: 195-203. PMID 8054311 DOI: 10.1016/0920-9964(94)90029-9  0.35
1994 Cannon TD, Zorrilla LE, Shtasel D, Gur RE, Gur RC, Marco EJ, Moberg P, Price RA. Neuropsychological functioning in siblings discordant for schizophrenia and healthy volunteers. Archives of General Psychiatry. 51: 651-61. PMID 8042914 DOI: 10.1001/Archpsyc.1994.03950080063009  0.341
1992 Shtasel DL, Gur RE, Gallacher F, Heimberg C, Cannon T, Gur RC. Phenomenology and functioning in first-episode schizophrenia Schizophrenia Bulletin. 18: 449-462. PMID 1411332 DOI: 10.1093/Schbul/18.3.449  0.394
1992 Shtasel DL, Gur RE, Gallacher F, Heimberg C, Gur RC. Gender differences in the clinical expression of schizophrenia Schizophrenia Research. 7: 225-231. PMID 1390401 DOI: 10.1016/0920-9964(92)90016-X  0.362
1991 Gur RE, Mozley PD, Resnick SM, Levick S, Erwin R, Saykin AJ, Gur RC. Relations among clinical scales in schizophrenia. The American Journal of Psychiatry. 148: 472-8. PMID 2006693 DOI: 10.1176/ajp.148.4.472  0.311
1989 Blonder LX, Gur RE, Gur RC, Saykin AJ, Hurtig HI. Neuropsychological functioning in hemiparkinsonism Brain and Cognition. 9: 244-257. PMID 2923715 DOI: 10.1016/0278-2626(89)90034-1  0.329
1989 Gur RE, Resnick SM, Gur RC. Laterality and frontality of cerebral blood flow and metabolism in schizophrenia: relationship to symptom specificity. Psychiatry Research. 27: 325-34. PMID 2785274 DOI: 10.1016/0165-1781(89)90147-9  0.383
Show low-probability matches.